Search Results
Viewing: 1551-1560 of 11699 | All
Research Employee Access
The following links are ONLY for current employees:
Article
Center for Cancer Genomics at the National Cancer Institute (NCI CCG) Project Team
The BCR is a laboratory and biorepository within the Biopathology Center (BPC) that supports multiple cancer genomics projects for the Center for Cancer Genomics (CCG) at the National Cancer Institute (NCI) and other contracted entities.
Article
CHTN Pediatric Division
The Cooperative Human Tissue Network (CHTN) facilitates access to human tissue for research, accelerating scientific discoveries in medical diagnoses and treatment. The Pediatric Division is managed by the Biopathology Center at Nationwide Children’s Hospital.
Article
About Us
The BCR at Nationwide Children's Hospital is composed of six primary workgroups: Client Services Logistics Histology Pathology and Virtual Microscopy Molecular Informatics This subdivision of workgroups creates a modular system which allows the BCR flexibility and variety in the functions it
Article
ALCHEMIST
The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, or ALCHEMIST, is a group of clinical trials for patients with certain types of early-stage non-small cell lung cancers (NSCLC) that have been treated surgically.
Article
Exceptional Responders
The National Cancer Institute (NCI) has embarked on the Exceptional Responders (ER) Initiative to understand the molecular underpinnings of exceptional responses to treatment, primarily via chemotherapy, in cancer patients.
Article
BCR Training Resources
TSS Training Webinar: Click here to download the training webinar. OpenClinica Training Manual: Click here to download the training manual. FFPE Scroll Calculuator: Click here to download the FFPE scroll calculator.
Article
Burkitt Lymphoma Genome Sequencing Project
The BCR serves as the biospecimen processing core for the Burkitt Lymphoma Genome Sequencing Project (BLGSP). Burkitt lymphoma is a type of non-Hodgkin lymphoma that occurs most often in children and young adults.
Article
Clinical Trials Sequencing Project
The Clinical Trials Sequencing Project (CTSP) will promote the use of genomics to explain the molecular basis of response and resistance to therapies studied in National Cancer Institute (NCI)-sponsored clinical trials of the National Clinical Trials Network (NCTN).
Article
Cancer Driver Discovery Project
The Cancer Driver Discovery Project (CDDP) aims to identify driver mutations that occur in two percent or more of cancer cases. Further explanation of the molecular causes of cancer through deeper characterization of tumors is expected to yield insights into tumor biology, leading to better